Zhanqi Liu
-
- Monoclonal and Polyclonal Antibodies Research 15
- Radiopharmaceutical Chemistry and Applications 7
-
- HER2/EGFR in Cancer Research 6
- CAR-T cell therapy research 3
-
- Immunotherapy and Immune Responses 3
-
- Glycosylation and Glycoproteins Research 6
- Protein purification and stability 3
-
- Cancer Research and Treatments 3
Zhanqi Liu
28 papers receiving 499 citations
Peers
Comparison fields: 5 of 78
- Radiology, Nuclear Medicine and Imaging 191
- Oncology 156
- Immunology 116
- Molecular Biology 212
- Electrochemistry 14
Countries citing papers authored by Zhanqi Liu
This map shows the geographic impact of Zhanqi Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhanqi Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhanqi Liu more than expected).
Fields of papers citing papers by Zhanqi Liu
This network shows the impact of papers produced by Zhanqi Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhanqi Liu. The network helps show where Zhanqi Liu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhanqi Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 63 | |
| 6 | 2024 | 15 | |
| 7 | 2023 | 1 | |
| 8 | 2022 | 4 | |
| 9 | 2021 | 20 | |
| 10 | 2021 | 2 | |
| 11 | 2020 | 11 | |
| 12 | 2018 | 41 | |
| 13 | 2018 | 1 | |
| 14 | 2016 | 8 | |
| 15 | 2016 | 15 | |
| 16 | 2012 | 25 | |
| 17 | 2012 | 19 | |
| 18 | 2003 | 20 | |
| 19 | 2003 | 24 | |
| 20 | 1993 | 17 |
About Zhanqi Liu
Zhanqi Liu is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Biotechnology, having authored 29 papers that have together received 507 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (15 papers), Radiopharmaceutical Chemistry and Applications (7 papers), Glycosylation and Glycoproteins Research (6 papers), HER2/EGFR in Cancer Research (6 papers), Cancer Research and Treatments (3 papers), CAR-T cell therapy research (3 papers), Protein purification and stability (3 papers) and Immunotherapy and Immune Responses (3 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (191 citations), Oncology (156 citations) and Immunology (116 citations). Zhanqi Liu has collaborated with scholars based in Australia, United States and China. Frequent co-authors include Andrew M. Scott, Lloyd J. Old, Fiona E. Smyth, Christina Cheers, Fook-Thean Lee, Angela Rigopoulos, Ian D. Davis, Wendie Hopkins, Huifan Li and Yusen Su. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Applied Physics Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.